Navigation Links
Curis Announces Hedgehog and Wnt Antagonist Data Presentation at,AACR

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr 17, 2007 - Curis, Inc. (NASDAQ:CRIS), a drug development company focused on novel targeted medicines primarily for cancer treatment, today announced that its data was included in two presentations at the 98th Annual Meeting of the American Association for Cancer Research (AACR).

At AACR, Curis also disclosed that its April 2005 discovery collaboration agreement with Genentech focused on developing drug candidates that target the Wnt signaling pathway, particularly for potential cancer indications. Abnormal activation of Wnt signaling is present in various cancers, including colon, breast and ovarian cancers. Developing drug candidates that are designed to inhibit, or antagonize, Wnt signaling could hopefully provide a potential option in certain cancers.

On April 14, data was presented during an Educational Session titled "Targeting the Wnt Pathway in Cancer," which included a discussion of the Curis-Genentech joint effort in the identification of small molecule inhibitors of the Wnt pathway, under the April 2005 discovery collaboration agreement. The parties' research efforts have yielded a class of Wnt antagonists that, in preclinical studies, inhibit the Wnt pathway by acting upstream of beta-catenin, which is believed to be an important molecular target in the Wnt pathway. Inhibiting such an upstream molecular target may represent an attractive approach for potential inhibition of the Wnt pathway in cancer cells with abnormally active Wnt signaling.

In addition to the Educational Session, a poster was also presented at the conference describing the use of Hedgehog antagonists in a preclinical pancreatic tumor model. In these studies, Genentech and Curis scientists used a potent small molecule antagonist of the Hedgehog pathway on mice implanted with primary human pancreatic cancer xenografts. The scientists found that antagonizing the Hedgehog pathway res
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
(Date:7/31/2015)... July 31, 2015 RnRMarketResearch.com ... market research report that provides an overview of ... data sourced from in-house databases, secondary and primary ... needles market products pipeline spread across 124 pages, ... 73 tables and 5 figures is now available ...
(Date:7/31/2015)... 2015  Boston Children,s Hospital physicians report the ... of their anatomy before undergoing high-risk brain procedures. ... in the brain,s blood vessels) that posed special ... the Journal of Neurosurgery: Pediatrics , the ... synthetic resins to create custom, high-fidelity models of ...
(Date:7/31/2015)... TAMPA, Fla. , July 31, 2015 /PRNewswire/ ... announced today that it has made a structured ... -based company specializing in milling, micronization and ... investment will help grow Powdersize,s business while simultaneously ... solutions to Xcelience,s portfolio of capabilities. ...
Breaking Medicine Technology:Syringes and Needles Market Products Pipeline Review 2015 Report 2Syringes and Needles Market Products Pipeline Review 2015 Report 3Syringes and Needles Market Products Pipeline Review 2015 Report 4Syringes and Needles Market Products Pipeline Review 2015 Report 53D Printing Helps Doctors Rehearse Complex Brain Procedures 23D Printing Helps Doctors Rehearse Complex Brain Procedures 33D Printing Helps Doctors Rehearse Complex Brain Procedures 4Xcelience Makes Structured Cash Investment in Powdersize 2Xcelience Makes Structured Cash Investment in Powdersize 3
... Sept. 27, 2011 Lockheed Martin Corporation (NYSE: ... The company, based in Diamond Bar, Calif., is the largest ... of Veterans Affairs (VA), processing more than 450,000 evaluations last ... case management services and health care expertise to the Department ...
... 2011 Masimo ... from a new study published in the Journal ... continuous hemoglobin (SpHb®) monitoring has absolute and trending accuracy ... with additional advantages.  Study highlights that "the ability to ...
Cached Medicine Technology:Published Study Demonstrates the Absolute and Trend Accuracy of Masimo Noninvasive and Continuous Total Hemoglobin (SpHb) Monitoring in Intensive Care Unit Patients 2Published Study Demonstrates the Absolute and Trend Accuracy of Masimo Noninvasive and Continuous Total Hemoglobin (SpHb) Monitoring in Intensive Care Unit Patients 3Published Study Demonstrates the Absolute and Trend Accuracy of Masimo Noninvasive and Continuous Total Hemoglobin (SpHb) Monitoring in Intensive Care Unit Patients 4Published Study Demonstrates the Absolute and Trend Accuracy of Masimo Noninvasive and Continuous Total Hemoglobin (SpHb) Monitoring in Intensive Care Unit Patients 5Published Study Demonstrates the Absolute and Trend Accuracy of Masimo Noninvasive and Continuous Total Hemoglobin (SpHb) Monitoring in Intensive Care Unit Patients 6
(Date:8/1/2015)... ... 2015 , ... Have you ever wondered what “Karma” really means? Does it even exist? Can ... , Vedic tradition, which gave birth to Hinduism, is one of the most ancient spiritual ... this tradition. According to the wisdom of this heritage, Karma is a very real and ...
(Date:8/1/2015)... CT (PRWEB) , ... August 01, 2015 , ... ... Point Partners I, L.P. (“GPP”) portfolio company has acquired Premier Physical Therapy & ... it into its portfolio of state-of-the-art clinics. , “Our acquisition of Premier Physical ...
(Date:8/1/2015)... ... , ... On March 19, 2015 Phil Valentine – the Executive Director of Connecticut Community for ... by stepping off Springer Mountain and heading north. Since that day, Phil has hiked over ... was greeted by friends and family. He visited CCAR and left an inspirational message ...
(Date:7/31/2015)... CA (PRWEB) , ... August 01, 2015 , ... Super Bowl 50 will ... National Football League’s biggest day each year is the Super Bowl. In the two weeks ... takes place from the host venue. The 2016 Super Bowl game will mark the 50th ...
(Date:7/31/2015)... ... , ... The 2nd annual Ride to Fight On will start and end ... The Ride to Fight On is a cycling fundraiser that benefits the West Cancer ... and The University of Tennessee Health Science Center. A health and wellness festival featuring ...
Breaking Medicine News(10 mins):Health News:Nithyananda Yoga Foundation to Conduct Global Webinar on Karma at No Charge on August 1st 2Health News:Professional Physical Therapy Now Largest Outpatient Physical Therapy Provider in Northeast With Acquisition of Premier Physical Therapy & Wellness 2Health News:Connecticut Executive Hikes Appalachian Trail to Raise Awareness About Recovery. 2Health News:Cheap 2016 Super Bowl Tickets at Levi's Stadium: Ticket Down Slashes Ticket Prices on Super Bowl 50 Tickets in Santa Clara, CA at Levi's Stadium 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 3
... unusual metals could form an effective treatment against colon and ... other drugs, according to research at the University of Warwick ... in the Journal of Medicinal Chemistry , showed that ... and Osmium, which are found in the same part of ...
... Macrophages, the scavenger cells of the body,s immune ... University School of Medicine researchers have identified one pathway ... causes a lupuslike autoimmune disease. The findings could ... of lupus in humans and potential drug treatments for ...
... other risks await, experts warn, , SUNDAY, Oct. 18 (HealthDay ... week -- a new study emerges touting the health benefits ... a pint of dark beer. , The benefits related to ... for instance, found that moderate alcohol consumption reduces the risk ...
... younger the child, the more likely the pain, says research led ... who play video games for more than an hour a day ... study has found. , The lead author of the study knows ... the idea to study joint pain among his classmates at Rossman ...
... , DES MOINES, Iowa, Oct. 16 The announcement by the ... to determine if three pigs from the Minnesota State Fair in ... in the U.S. swine herd provides an opportunity to stress three ... you cannot get the H1N1 flu from eating pork. Pork and ...
... WALTHAM, Mass., Oct. 16 Augmenix announced today that it ... round was led by Ascension Health Ventures (AHV) in St. ... and Pinnacle Ventures. Also participating were Catalyst Health Ventures ... radiation oncology has traditionally been of a large capital equipment ...
Cached Medicine News:Health News:Metals could forge new cancer drug 2Health News:Stanford study identifies cellular mechanism that causes lupuslike symptoms in mice 2Health News:Stanford study identifies cellular mechanism that causes lupuslike symptoms in mice 3Health News:Drinking Your Way to Health? Perhaps Not 2Health News:Drinking Your Way to Health? Perhaps Not 3Health News:Video Games Can Play Havoc With Kids' Joints 2Health News:Video Games Can Play Havoc With Kids' Joints 3Health News:Augmenix, Inc. Closes $6.1 Million Financing 2
Double-ended. 4 mm x 4 mm round end and 3 mm spatula end. Designated most popular model or size....
4 mm wide tip....
Double-ended. 3 mm x 5 mm curette end and 3 mm spatula end....
2.5 mm x 4 mm opening. Hexagonal handle....
Medicine Products: